NERV / Minerva Neurosciences, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Minerva Neurosciences, Inc.
US ˙ NasdaqCM ˙ US6033802058

Utestående aktier 6,993,406 shares
Insideraktier5 401 084 shares
Insynsägande77,23 %
Totalt antal insynspersoner32
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

0 ( )

5021 out of 11275

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

0.000 %( )

5030 out of 11219

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

Minerva Neurosciences, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Frederick W Ahlholm SVP, CFO and Secretary - [O] 17 518 17 518
Plc Barclays 10% Owner - [10%] 196 800 196 800
Boehringer Ingelheim International Gmbh 10% Owner - [10%] 2 550 000 2 550 000
Marc D Beer Director - [D] 50 000 6 250
Care Capital III LLC 10% Owner - [10%] 1 662 592 207 824
Care Capital Investments III L.P. 10% Owner - [10%] 1 662 592 207 824
Care Capital Offshore Investments III LP 10% Owner - [10%] 1 662 592 207 824
William F Doyle Director - [D] 26 111 3 264
Michael Davidson Chief Medical Officer - [O] 0 0
Rubertis Francesco De Director, 10% Owner - [D] [10%] 4 690 906 586 363
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Hans Peter Hasler Director - [D] 10 000 1 250
Jeryl L Hilleman Director - [D] 1 000 125
Venture Associates III Ltd Index 10% Owner - [10%] 3 899 189 487 399
Venture Associates IV Ltd Index 10% Owner - [10%] 3 899 189 487 399
Venture Associates V Ltd Index 10% Owner - [10%] 3 899 189 487 399
& Johnson Johnson 10% Owner - [10%] 0 0
Johnson & Johnson Innovation - JJDC, Inc. 10% Owner - [10%] 0 0
David Kupfer Director - [D] 163 553 20 444
Fouzia Laghrissi-Thode Director - [D] 0 0
Levine Mark S. SVP,General Counsel & Sec. - [O] 0 0
Remy Luthringer CEO, Director - [D] [O] 184 819 184 819
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Michele Ollier Director, 10% Owner - [D] [10%] 4 690 906 586 363
Lorenzo Pellegrini Director, 10% Owner - [D] [10%] 3 883 212 485 402
Geoff Race President - [O] 51 324 51 324
Reilly Joseph H. SVP & Chief Operating Officer - [O] 31 747 3 968
Russell Richard E. President - [O] 33 770 4 221
Jay Saoud 100 000
Devin Whittemore Smith 85 000
Heek G Jan Van Director - [D] 20 333 2 542
Nico Vandervelpen Director - [D] 0 0
Coelho Rogerio Vivaldi President and CEO, Director - [D] [O] 41 667 5 208
(Jersey) SLP Yucca 10% Owner - [10%] 3 899 189 487 399

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NERV / Minerva Neurosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2020-09-10 VAN HEEK G JAN 7 000 2,9700 875 23,7600 20 790 78 4.0100 −17 281 −83,12
2019-06-27 DOYLE WILLIAM F 3 500 5,5000 438 44,0000 19 250
2019-06-26 HILLEMAN JERYL L 1 000 5,2500 125 42,0000 5 250
2019-06-26 Kupfer David 10 000 5,5500 1 250 44,4000 55 500
2019-06-26 VAN HEEK G JAN 10 000 5,3700 1 250 42,9600 53 700
2019-06-26 HASLER HANS PETER 10 000 5,6000 1 250 44,8000 56 000
2018-12-20 DOYLE WILLIAM F 2 000 6,5000 250 52,0000 13 000
2018-12-11 DOYLE WILLIAM F 4 000 7,9500 500 63,6000 31 800
2018-12-10 DOYLE WILLIAM F 2 000 8,0000 250 64,0000 16 000

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

NERV / Minerva Neurosciences, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NERV / Minerva Neurosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2023-05-02 Luthringer Remy 3 641 3,7600 3 641 3,7600 13 690 365 2.3300 −5 206 −38,03
2023-05-01 Luthringer Remy 23 753 3,8500 23 753 3,8500 91 449
2023-05-01 Race Geoff 22 082 3,8500 22 082 3,8500 85 016
2023-05-01 Ahlholm Frederick W 3 580 4,4800 3 580 4,4800 16 038
2021-12-01 Kupfer David 55 635 0,8800 6 954 7,0400 48 959
2020-12-16 Reilly Joseph H. 3 228 2,6400 404 21,1200 8 522
2020-12-16 Race Geoff 6 190 2,6400 774 21,1200 16 342
2020-12-16 Luthringer Remy 1 300 2,6400 162 21,1200 3 432
2020-12-16 Ahlholm Frederick W 1 845 2,6400 231 21,1200 4 871

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

NERV / Minerva Neurosciences, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2023-07-07 3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH NERV Common Stock D 1 275 000
2023-05-02 2023-05-02 4 Luthringer Remy NERV Common Stock S - Sale D 3,7600 −3 641 −14 68 994
2023-05-02 2023-05-01 4 Luthringer Remy NERV Common Stock S - Sale D 3,8500 −23 753 −91 72 635
2023-05-02 2023-04-28 4 Luthringer Remy NERV Common Stock A - Award D 88 077 96 388
2023-05-02 2023-05-01 4 Race Geoff NERV Common Stock S - Sale D 3,8500 −22 082 −85 51 324
2023-05-02 2023-04-28 4 Race Geoff NERV Common Stock A - Award D 46 987 73 406
2023-05-02 2023-05-01 4 Ahlholm Frederick W NERV Common Stock S - Sale D 4,4800 −3 580 −16 17 518
2023-05-02 2023-04-28 4 Ahlholm Frederick W NERV Common Stock A - Award D 19 843 21 098
2022-08-10 3 BARCLAYS PLC By Barclays Capital Inc. NERV Common Stock, $0.0001 par value per share I 196 800
2022-08-10 3 BARCLAYS PLC By Barclays Bank PLC NERV Common Stock, $0.0001 par value per share I 408 430
2022-02-18 2022-02-16 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 0,79 180 000 180 000
2022-02-18 2022-02-16 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 0,79 505 000 505 000
2022-02-18 2022-02-16 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 0,79 200 000 200 000
2021-12-03 2021-12-01 4 Kupfer David NERV Common Stock S - Sale D 0,8800 −55 635 −49 163 553
2021-06-16 2021-06-11 4 HASLER HANS PETER NERV Stock Option (right to buy) A - Award D 2,90 20 000 20 000
2021-06-15 2021-06-11 4 DOYLE WILLIAM F NERV Stock Option (right to buy) A - Award D 2,90 40 000 40 000
2021-06-15 2021-06-11 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 2,90 20 000 20 000
2021-06-15 2021-06-11 4 HILLEMAN JERYL L NERV Stock Option (right to buy) A - Award D 2,90 20 000 20 000
2021-06-15 2021-06-11 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 2,90 20 000 20 000
2021-06-15 2021-06-11 4 Kupfer David NERV Stock Option (right to buy) A - Award D 2,90 20 000 20 000
2020-12-16 2020-12-16 4 Reilly Joseph H. NERV Common Stock S - Sale D 2,6400 −3 228 −9 31 747
2020-12-16 2020-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit M - Exercise D −8 750 0
2020-12-16 2020-12-14 4 Reilly Joseph H. NERV Common Stock M - Exercise D 8 750 34 975
2020-12-16 2020-12-16 4 Race Geoff NERV Common Stock S - Sale D 2,6400 −6 190 −16 211 354
2020-12-16 2020-12-14 4 Race Geoff NERV Restricted Stock Unit M - Exercise D −12 500 0
2020-12-16 2020-12-14 4 Race Geoff NERV Common Stock M - Exercise D 12 500 217 544
2020-12-16 2020-12-16 4 Luthringer Remy NERV Common Stock S - Sale D 2,6400 −1 300 −3 66 490
2020-12-16 2020-12-14 4 Luthringer Remy NERV Restricted Stock Unit M - Exercise D −18 750 0
2020-12-16 2020-12-14 4 Luthringer Remy NERV Common Stock M - Exercise D 18 750 67 790
2020-12-16 2020-12-16 4 Ahlholm Frederick W NERV Common Stock S - Sale D 2,6400 −1 845 −5 10 039
2020-12-16 2020-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit M - Exercise D −5 000 0
2020-12-16 2020-12-14 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5 000 11 884
2020-10-14 2020-10-13 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 3,50 200 000 200 000
2020-10-14 2020-10-13 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 3,50 140 000 140 000
2020-10-14 2020-10-13 4 Smith Devin Whittemore NERV Employee Stock Option (right to buy) A - Award D 3,50 85 000 85 000
2020-10-14 2020-10-13 4 Davidson Michael NERV Employee Stock Option (right to buy) A - Award D 3,50 85 000 85 000
2020-10-14 2020-10-13 4 Saoud Jay NERV Employee Stock Option (right to buy) A - Award D 3,50 100 000 100 000
2020-10-14 2020-10-13 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 3,50 85 000 85 000
2020-10-14 2020-10-13 4 Reilly Joseph H. NERV Employee Stock Option (right to buy) A - Award D 3,50 85 000 85 000
2020-09-11 2020-09-10 4 VAN HEEK G JAN NERV Common Stock P - Purchase D 2,9700 7 000 21 20 333
2020-08-17 2020-06-19 4 Smith Devin Whittemore NERV Employee Stock Option (right to buy) A - Award D 7,11 153 531 153 531
2020-08-17 2020-06-19 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 7,11 275 568 275 568
2020-08-17 2020-06-19 4 Davidson Michael NERV Employee Stock Option (right to buy) A - Award D 7,11 137 784 137 784
2020-08-17 2020-06-19 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 7,11 354 302 354 302
2020-08-17 2020-06-19 4 Reilly Joseph H. NERV Employee Stock Option (right to buy) A - Award D 7,11 153 531 153 531
2020-08-17 2020-06-19 4 Russell Richard E. NERV Employee Stock Option (right to buy) A - Award D 7,11 185 025 185 025
2020-08-17 2020-06-19 4 Saoud Jay NERV Employee Stock Option (right to buy) A - Award D 7,11 236 202 236 202
2020-08-17 2020-06-19 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 7,11 137 784 137 784
2020-06-12 2020-06-11 4 DOYLE WILLIAM F NERV Stock Option (right to buy) A - Award D 3,40 40 000 40 000
2020-06-12 2020-06-11 4 HASLER HANS PETER NERV Stock Option (right to buy) A - Award D 3,40 20 000 20 000
2020-06-12 2020-06-11 4 HILLEMAN JERYL L NERV Stock Option (right to buy) A - Award D 3,40 20 000 20 000
2020-06-12 2020-06-11 4 Kupfer David NERV Stock Option (right to buy) A - Award D 3,40 20 000 20 000
2020-06-12 2020-06-11 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 3,40 20 000 20 000
2020-06-12 2020-06-11 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 3,40 20 000 20 000
2020-05-27 2020-05-26 4 Ahlholm Frederick W NERV Common Stock S - Sale D 15,0000 −8 339 −125 6 884
2020-01-03 2019-12-31 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 7,11 74 432 74 432
2020-01-03 2019-12-31 4 Reilly Joseph H. NERV Employee Stock Option (right to buy) A - Award D 7,11 41 469 41 469
2020-01-03 2019-12-31 4 Russell Richard E. NERV Employee Stock Option (right to buy) A - Award D 7,11 49 975 49 975
2020-01-03 2019-12-31 4 Saoud Jay NERV Employee Stock Option (right to buy) A - Award D 7,11 63 798 63 798
2020-01-03 2019-12-31 4 Smith Devin Whittemore NERV Employee Stock Option (right to buy) A - Award D 7,11 41 469 41 469
2020-01-03 2019-12-31 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 7,11 37 216 37 216
2020-01-03 2019-12-31 4 Davidson Michael NERV Employee Stock Option (right to buy) A - Award D 7,11 37 216 37 216
2020-01-03 2019-12-31 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 7,11 95 698 95 698
2019-12-17 2019-12-17 4 Race Geoff NERV Common Stock S - Sale D 7,1000 −5 826 −41 205 044
2019-12-17 2019-12-14 4 Race Geoff NERV Restricted Stock Unit M - Exercise D −12 500 12 500
2019-12-17 2019-12-14 4 Race Geoff NERV Common Stock M - Exercise D 12 500 210 870
2019-12-17 2019-12-17 4 Reilly Joseph H. NERV Common Stock S - Sale D 7,1000 −2 724 −19 26 225
2019-12-17 2019-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit M - Exercise D −8 750 8 750
2019-12-17 2019-12-14 4 Reilly Joseph H. NERV Common Stock M - Exercise D 8 750 28 949
2019-12-17 2019-12-17 4 Ahlholm Frederick W NERV Common Stock S - Sale D 7,1000 −1 557 −11 15 223
2019-12-17 2019-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit M - Exercise D −5 000 5 000
2019-12-17 2019-12-14 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5 000 16 780
2019-12-17 2019-12-17 4 Luthringer Remy NERV Common Stock S - Sale D 7,1000 −2 412 −17 49 040
2019-12-17 2019-12-14 4 Luthringer Remy NERV Restricted Stock Unit M - Exercise D −18 750 18 750
2019-12-17 2019-12-14 4 Luthringer Remy NERV Common Stock M - Exercise D 18 750 51 452
2019-12-13 2019-12-12 4 Russell Richard E. NERV Common Stock S - Sale D 7,4200 −3 113 −23 33 770
2019-07-01 2019-06-27 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 5,5000 3 500 19 26 111
2019-06-27 2019-06-26 4 Kupfer David NERV Common Stock P - Purchase D 5,5500 10 000 56 219 188
2019-06-27 2019-06-26 4 HASLER HANS PETER NERV Common Stock P - Purchase D 5,6000 10 000 56 10 000
2019-06-27 2019-06-26 4 HILLEMAN JERYL L NERV Common Stock P - Purchase D 5,2500 1 000 5 1 000
2019-06-27 2019-06-26 4 VAN HEEK G JAN NERV Common Stock P - Purchase D 5,3700 10 000 54 13 333
2019-06-26 2019-06-24 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,0144 −197 000 −1 185 3 899 189
2019-06-21 2019-06-20 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,3413 −33 575 −146 4 096 189
2019-06-21 2019-06-19 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,4425 −77 243 −343 4 129 764
2019-06-19 2019-06-18 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,4393 −49 675 −221 4 207 007
2019-06-19 2019-06-17 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,4487 −56 243 −250 4 256 682
2019-06-17 2019-06-14 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,4971 −25 169 −113 4 312 925
2019-06-17 2019-06-13 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,5133 −53 298 −241 4 338 094
2019-06-13 2019-06-12 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,5719 −26 901 −123 4 391 392
2019-06-13 2019-06-11 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 4,7769 −33 150 −158 4 418 293
2019-06-13 2019-06-12 4 DOYLE WILLIAM F NERV Stock option (right to buy) A - Award D 4,50 20 000 20 000
2019-05-31 2019-05-31 4 Kupfer David NERV Stock Option (right to buy) A - Award D 5,21 20 000 20 000
2019-05-31 2019-05-31 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 5,21 20 000 20 000
2019-05-31 2019-05-31 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 5,21 20 000 20 000
2019-05-31 2019-05-31 4 HILLEMAN JERYL L NERV Stock Option (right to buy) A - Award D 5,21 20 000 20 000
2019-05-31 2019-05-31 4 DOYLE WILLIAM F NERV Stock Option (right to buy) A - Award D 5,21 20 000 20 000
2019-05-31 2019-05-31 4 HASLER HANS PETER NERV Stock Option (right to buy) A - Award D 5,21 20 000 20 000
2019-05-21 2019-05-20 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,0750 −200 −1 4 451 443
2019-05-21 2019-05-17 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,0164 −22 718 −137 4 451 643
2019-05-16 2019-05-16 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,3715 −44 836 −286 4 474 361
2019-05-16 2019-05-15 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 6,6357 −53 418 −354 4 519 197
2019-05-16 2019-05-14 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 7,0548 −36 574 −258 4 572 615
2018-12-26 2018-12-20 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 6,5000 2 000 13 22 611
2018-12-18 2018-12-17 4 Reilly Joseph H. NERV Common Stock S - Sale D 7,4600 −2 728 −20 20 199
2018-12-18 2018-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit M - Exercise D −8 750 17 500
2018-12-18 2018-12-14 4 Reilly Joseph H. NERV Common Stock M - Exercise D 8 750 22 927
2018-12-18 2018-12-17 4 Luthringer Remy NERV Common Stock S - Sale D 7,4600 −2 604 −19 32 702
2018-12-18 2018-12-14 4 Luthringer Remy NERV Restricted Stock Unit M - Exercise D −18 750 37 500
2018-12-18 2018-12-14 4 Luthringer Remy NERV Common Stock M - Exercise D 18 750 35 306
2018-12-18 2018-12-17 4 Ahlholm Frederick W NERV Common Stock S - Sale D 7,4600 −1 559 −12 11 780
2018-12-18 2018-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit M - Exercise D −5 000 10 000
2018-12-18 2018-12-14 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5 000 13 339
2018-12-18 2018-12-17 4 Race Geoff NERV Common Stock S - Sale D 7,4600 −5 999 −45 198 370
2018-12-18 2018-12-14 4 Race Geoff NERV Restricted Stock Unit M - Exercise D −12 500 25 000
2018-12-18 2018-12-14 4 Race Geoff NERV Common Stock M - Exercise D 12 500 204 369
2018-12-13 2018-12-12 4 Russell Richard E. NERV Common Stock S - Sale D 7,9600 −3 117 −25 36 883
2018-12-13 2018-12-11 4 Russell Richard E. NERV Employee Stock Option (right to buy) A - Award D 7,96 260 000 260 000
2018-12-13 2018-12-11 4 Saoud Jay NERV Employee Stock Option (right to buy) A - Award D 7,96 96 000 96 000
2018-12-13 2018-12-11 4 Smith Devin Whittemore NERV Employee Stock Option (right to buy) A - Award D 7,96 120 000 120 000
2018-12-13 2018-12-11 4 Ahlholm Frederick W NERV Employee Stock Option (right to buy) A - Award D 7,96 120 000 120 000
2018-12-13 2018-12-11 4 Davidson Michael NERV Employee Stock Option (right to buy) A - Award D 7,96 175 000 175 000
2018-12-13 2018-12-11 4 Luthringer Remy NERV Employee Stock Option (right to buy) A - Award D 7,96 410 000 410 000
2018-12-13 2018-12-11 4 Race Geoff NERV Employee Stock Option (right to buy) A - Award D 7,96 175 000 175 000
2018-12-13 2018-12-11 4 Reilly Joseph H. NERV Employee Stock Option (right to buy) A - Award D 7,96 120 000 120 000
2018-12-12 2018-12-11 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 7,9500 4 000 32 20 611
2018-12-12 2018-12-10 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 8,0000 2 000 16 16 611
2018-11-21 2018-11-20 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 8,2000 2 000 16 14 611
2018-10-15 2018-10-11 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 10,0000 600 6 12 611
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) M - Exercise D 5,19 −10 000 47 524
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) M - Exercise D 4,71 −15 000 27 400
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Common Stock S - Sale D 12,6200 −1 700 −21 14 177
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Common Stock S - Sale D 12,0200 −23 300 −280 15 877
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Common Stock M - Exercise D 5,1900 10 000 52 39 177
2018-10-03 2018-10-01 4 Reilly Joseph H. NERV Common Stock M - Exercise D 4,7100 15 000 71 29 177
2018-10-03 2018-10-01 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 12,3509 −15 444 −191 4 609 189
2018-10-01 2018-09-28 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 12,6151 −34 589 −436 4 624 633
2018-10-01 2018-09-27 4 Index Venture Associates III Ltd NERV Common Stock S - Sale I 12,5702 −31 684 −398 4 659 222
2018-09-19 2018-09-17 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 10,5000 1 800 19 12 011
2018-09-17 2018-09-14 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 10,5000 200 2 10 211
2018-09-17 2018-09-13 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 10,5000 2 000 21 10 011
2018-09-11 2018-09-11 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 9,7200 4 011 39 8 011
2018-09-11 2018-09-10 4 DOYLE WILLIAM F NERV Common Stock P - Purchase D 9,8800 4 000 40 4 000
2018-08-24 2018-08-23 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) M - Exercise D 4,71 −25 000 42 400
2018-08-24 2018-08-23 4 Reilly Joseph H. NERV Common Stock S - Sale D 10,0000 −25 000 −250 14 177
2018-08-24 2018-08-23 4 Reilly Joseph H. NERV Common Stock M - Exercise D 4,7100 25 000 118 39 177
2018-08-02 2018-08-01 4 Smith Devin Whittemore NERV Employee Stock Option (Righ to Buy) A - Award D 7,95 200 000 200 000
2018-08-02 2018-08-01 4 DOYLE WILLIAM F NERV Stock Option (Right to Buy) A - Award D 7,95 20 000 20 000
2018-07-17 2018-07-16 4 HILLEMAN JERYL L NERV Stock Option (Right to Buy) A - Award D 8,20 40 000 40 000
2018-06-11 2018-06-07 4 VAN HEEK G JAN NERV Stock Option (Right to Buy) A - Award D 8,25 20 000 20 000
2018-06-11 2018-06-07 4 DOYLE WILLIAM F NERV Stock Option (Right to Buy) A - Award D 8,25 20 000 20 000
2018-06-11 2018-06-07 4 HASLER HANS PETER NERV Stock Option (Right to Buy) A - Award D 8,25 20 000 20 000
2018-06-11 2018-06-07 4 Kupfer David NERV Stock Option (Right to Buy) A - Award D 8,25 20 000 20 000
2018-06-11 2018-06-07 4 Laghrissi-Thode Fouzia NERV Stock Option (Right to Buy) A - Award D 8,25 20 000 20 000
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 10,20 12 500 12 500
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 10,00 12 500 12 500
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 10,00 −12 500 0
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 10,20 −12 500 0
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 4,34 7 500 7 500
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 4,34 −7 500 0
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 6,00 127 513 127 513
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 6,00 −127 513 0
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 9,49 80 356 80 356
2018-02-02 2018-01-31 4 Beer Marc D NERV Stock Option (Right to Buy) D - Sale to Issuer D 9,49 −80 356 0
2018-01-04 2018-01-02 4 Luthringer Remy NERV Employee Stock Option (Right to Buy) A - Award D 6,20 200 000 200 000
2017-12-15 2017-12-14 4 Race Geoff NERV Restricted Stock Unit M - Exercise D −12 500 37 500
2017-12-15 2017-12-14 4 Race Geoff NERV Common Stock S - Sale D 5,7900 −5 829 −34 191 869
2017-12-15 2017-12-14 4 Race Geoff NERV Common Stock M - Exercise D 12 500 197 698
2017-12-15 2017-12-13 4 Race Geoff NERV Employee Stock Option (Right to Buy) A - Award D 6,10 200 000 200 000
2017-12-15 2017-12-13 4 Saoud Jay NERV Employee Stock Option (Right to Buy) A - Award D 6,10 175 000 175 000
2017-12-15 2017-12-13 4 Davidson Michael NERV Employee Stock Option (Right to Buy) A - Award D 6,10 125 000 125 000
2017-12-15 2017-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit M - Exercise D −5 000 15 000
2017-12-15 2017-12-14 4 Ahlholm Frederick W NERV Common Stock S - Sale D 5,8000 −1 661 −10 8 339
2017-12-15 2017-12-14 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5 000 10 000
2017-12-15 2017-12-13 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) A - Award D 6,10 120 000 120 000
2017-12-15 2017-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit M - Exercise D −8 750 26 250
2017-12-15 2017-12-14 4 Reilly Joseph H. NERV Common Stock S - Sale D 5,8000 −2 906 −17 14 177
2017-12-15 2017-12-14 4 Reilly Joseph H. NERV Common Stock M - Exercise D 8 750 17 083
2017-12-15 2017-12-13 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) A - Award D 6,10 120 000 120 000
2017-12-15 2017-12-14 4 Luthringer Remy NERV Restricted Stock Unit M - Exercise D −18 750 56 250
2017-12-15 2017-12-14 4 Luthringer Remy NERV Common Stock S - Sale D 5,8500 −2 194 −13 16 556
2017-12-15 2017-12-14 4 Luthringer Remy NERV Common Stock M - Exercise D 18 750 18 750
2017-12-15 2017-12-13 4 Luthringer Remy NERV Employee Stock Option (Right to Buy) A - Award D 6,10 350 000 350 000
2017-12-12 2017-12-10 4 DOYLE WILLIAM F NERV Option Grant (Right to Buy) A - Award D 5,70 40 000 40 000
2017-12-12 2017-12-10 4 HASLER HANS PETER NERV Option Grant (Right to Buy) A - Award D 5,70 40 000 40 000
2017-12-12 2017-12-11 4 Russell Richard E. NERV Employee Stock option (Right to Buy) A - Award D 6,05 775 000 775 000
2017-12-12 2017-12-11 4 Russell Richard E. NERV Common Stock A - Award D 40 000 40 000
2017-09-14 2017-08-29 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. NERV Common Stock J - Other I 0,0001 −3 892 256 −0 0
2017-09-05 2017-09-01 4 Saoud Jay NERV Employee Stock Option (Right to Buy) A - Award D 6,45 100 000 100 000
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) A - Award D 10,20 12 500 12 500
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) A - Award D 10,00 12 500 12 500
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) D - Sale to Issuer D 10,00 −12 500 0
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) D - Sale to Issuer D 10,20 −12 500 0
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) A - Award D 4,71 25 000 25 000
2017-07-26 2017-07-24 4 Vandervelpen Nico NERV Stock Option (Right to Buy) D - Sale to Issuer D 4,71 −25 000 0
2017-06-05 2017-06-01 4 VAN HEEK G JAN NERV Stock Option (Right to Buy) A - Award D 10,00 12 500 12 500
2017-06-05 2017-06-01 4 Vandervelpen Nico NERV Stock Option (Right to Buy) A - Award D 10,00 12 500 12 500
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) M - Exercise D 4,71 −7 250 49 750
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) M - Exercise D 5,19 −14 381 43 143
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Common Stock S - Sale D 11,0000 −10 381 −114 5 000
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Common Stock S - Sale D 10,0000 −11 250 −112 15 381
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 4,7100 7 250 34 26 631
2017-06-05 2017-06-01 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 5,1900 14 381 75 19 381
2017-06-05 2017-06-01 4 Laghrissi-Thode Fouzia NERV Stock Option (Right to Buy) A - Award D 10,00 12 500 12 500
2017-06-05 2017-06-01 4 Kupfer David NERV Stock Option (Right to Buy) A - Award D 10,00 12 500 12 500
2017-06-05 2017-06-01 4 Levine Mark S. NERV Employee Stock Option (Right to Buy) M - Exercise D 5,19 −17 500 39 774
2017-06-05 2017-06-01 4 Levine Mark S. NERV Common Stock S - Sale D 11,0000 −17 500 −192 0
2017-06-05 2017-06-01 4 Levine Mark S. NERV Common Stock M - Exercise D 5,1900 17 500 91 17 500
2017-06-05 2017-06-01 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 10,00 12 500 12 500
2017-03-21 2017-03-20 4 Beer Marc D NERV Common Stock P - Purchase D 7,8900 25 000 197 50 000
2017-03-21 2017-03-17 4 Beer Marc D NERV Common Stock P - Purchase D 8,3400 25 000 208 25 000
2017-02-07 2017-02-06 4 Luthringer Remy NERV Stock Option (Right to Buy) M - Exercise D 4,71 −2 185 285 719
2017-02-07 2017-02-06 4 Luthringer Remy NERV Common Stock S - Sale D 11,0000 −2 185 −24 0
2017-02-07 2017-02-06 4 Luthringer Remy NERV Common Stock M - Exercise D 4,7100 2 185 10 2 185
2017-02-07 2017-02-03 4 Luthringer Remy NERV Stock Option (Right to Buy) M - Exercise D 4,71 −32 096 287 904
2017-02-07 2017-02-03 4 Luthringer Remy NERV Common Stock S - Sale D 11,0200 −32 096 −354 0
2017-02-07 2017-02-03 4 Luthringer Remy NERV Common Stock M - Exercise D 4,7100 32 096 151 32 096
2017-02-07 2017-02-06 4 Race Geoff NERV Common Stock S - Sale D 11,0000 −1 692 −19 185 198
2017-02-07 2017-02-03 4 Race Geoff NERV Common Stock S - Sale D 11,0200 −19 758 −218 186 890
2017-01-13 2017-01-11 4 Reilly Joseph H. NERV Stock Option (Right to Buy) M - Exercise D 4,71 −1 600 67 400
2017-01-13 2017-01-11 4 Reilly Joseph H. NERV Common Stock S - Sale D 12,0300 −1 600 −19 8 333
2017-01-13 2017-01-11 4 Reilly Joseph H. NERV Common Stock M - Exercise D 4,7100 1 600 8 9 933
2017-01-06 2017-01-04 4 Levine Mark S. NERV Stock Option (Right to Buy) M - Exercise D 5,19 −250 57 274
2017-01-06 2017-01-04 4 Levine Mark S. NERV Stock Option (Right to Buy) M - Exercise D 4,71 −17 250 51 750
2017-01-06 2017-01-04 4 Levine Mark S. NERV Common Stock S - Sale D 12,0000 −17 500 −210 0
2017-01-06 2017-01-04 4 Levine Mark S. NERV Common Stock M - Exercise D 5,1900 250 1 17 500
2017-01-06 2017-01-04 4 Levine Mark S. NERV Common Stock M - Exercise D 4,7100 17 250 81 17 250
2017-01-05 2017-01-03 4 Davidson Michael NERV Stock Option (Right to Buy) A - Award D 11,75 145 000 145 000
2016-12-29 2016-12-27 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) M - Exercise D 4,71 −12 000 57 000
2016-12-29 2016-12-27 4 Ahlholm Frederick W NERV Common Stock S - Sale D 12,5100 −17 000 −213 5 000
2016-12-29 2016-12-27 4 Ahlholm Frederick W NERV Common Stock M - Exercise D 4,7100 12 000 57 22 000
2016-12-20 3 Davidson Michael NERV Common Stock D 0
2016-12-16 2016-12-14 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) A - Award D 13,45 35 000 35 000
2016-12-16 2016-12-14 4 Ahlholm Frederick W NERV Restricted Stock Unit A - Award D 20 000 20 000
2016-12-16 2016-12-14 4 Race Geoff NERV Employee Stock Option (Right to Buy) A - Award D 13,45 100 000 100 000
2016-12-16 2016-12-14 4 Race Geoff NERV Restricted Stock Unit A - Award D 50 000 50 000
2016-12-16 2016-12-14 4 Luthringer Remy NERV Stock Option (Right to Buy) A - Award D 13,45 150 000 150 000
2016-12-16 2016-12-14 4 Luthringer Remy NERV Restricted Stock Unit A - Award D 75 000 75 000
2016-12-16 2016-12-14 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) A - Award D 13,45 60 000 60 000
2016-12-16 2016-12-14 4 Reilly Joseph H. NERV Restricted Stock Unit A - Award D 35 000 35 000
2016-12-16 2016-12-14 4 Levine Mark S. NERV Employee Stock Option (Right to Buy) A - Award D 13,45 35 000 35 000
2016-12-16 2016-12-14 4 Levine Mark S. NERV Restricted Stock Units A - Award D 20 000 20 000
2016-12-14 2016-12-12 4 Ollier Michele See Footnotes NERV Warrant Shares X - Other I 5,77 −202 634 0
2016-12-14 2016-12-12 4 Ollier Michele See Footnotes NERV Common Stock X - Other I 5,7720 202 634 1 170 4 690 906
2016-12-14 2016-12-12 4 De Rubertis Francesco See Footnotes NERV Warrant Shares X - Other I 5,77 −202 634 0
2016-12-14 2016-12-12 4 De Rubertis Francesco See Footnotes NERV Common Stock X - Other I 5,7720 202 634 1 170 4 690 906
2016-12-14 2016-12-12 4 Index Venture Associates III Ltd See Footnotes NERV Warrant Shares X - Other I 5,77 −202 634 0
2016-12-14 2016-12-12 4 Index Venture Associates III Ltd See Footnotes NERV Common Stock X - Other I 5,7720 202 634 1 170 4 690 906
2016-08-12 2016-08-10 4 Ollier Michele See Footnotes NERV Common Stock S - Sale I 10,0000 −1 000 000 −10 000 4 488 272
2016-08-12 2016-08-10 4 De Rubertis Francesco See Footnotes NERV Common Stock S - Sale I 10,0000 −1 000 000 −10 000 4 488 272
2016-08-12 2016-08-10 4 Index Venture Associates III Ltd See Footnotes NERV Common Stock S - Sale I 10,0000 −1 000 000 −10 000 4 488 272
2016-06-21 2016-06-21 4 Kupfer David By wife NERV Common Stock P - Purchase I 10,7250 27 935 300 27 935
2016-06-21 2016-06-20 4 Kupfer David NERV Common Stock P - Purchase D 10,9530 27 700 303 209 188
2016-06-17 2016-06-16 4 Beer Marc D NERV Stock Option (right to buy) A - Award D 10,20 12 500 12 500
2016-06-17 2016-06-16 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 10,20 12 500 12 500
2016-06-17 2016-06-16 4 Vandervelpen Nico NERV Stock Option (right to buy) A - Award D 10,20 12 500 12 500
2016-06-17 2016-06-16 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 10,20 12 500 12 500
2016-06-17 2016-06-16 4 Kupfer David NERV Stock Option (right to buy) A - Award D 10,20 12 500 12 500
2016-03-18 2016-03-17 4 Kupfer David NERV Common Stock P - Purchase D 5,5100 181 488 1 000 181 488
2016-02-12 2015-03-18 5 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. NERV Common Stock P - Purchase I 4,9300 607 903 2 997 3 892 256
2015-12-08 2015-12-04 4 Levine Mark S. NERV Stock Option (right to buy) A - Award D 4,71 69 000 69 000
2015-12-08 2015-12-04 4 Reilly Joseph H. NERV Stock Option (right to buy) A - Award D 4,71 69 000 69 000
2015-12-08 2015-12-04 4 Race Geoff NERV Stock Option (right to buy) A - Award D 4,71 175 000 175 000
2015-12-08 2015-12-04 4 Luthringer Remy NERV Stock Option (right to buy) A - Award D 4,71 320 000 320 000
2015-12-08 2015-12-04 4 Ahlholm Frederick W NERV Stock Option (right to buy) A - Award D 4,71 69 000 69 000
2015-12-08 2015-12-04 4 Vandervelpen Nico NERV Stock Option (right to buy) A - Award D 4,71 25 000 25 000
2015-11-03 3 Kupfer David NERV Common Stock D 0
2015-11-03 3 Kupfer David NERV Common Stock D 0
2015-11-03 2015-11-02 4 Kupfer David NERV Stock Option (right to buy) A - Award D 5,41 25 000 25 000
2015-06-18 2015-06-17 4 Laghrissi-Thode Fouzia NERV Stock Option (right to buy) A - Award D 25 000 25 000
2015-05-18 3 Laghrissi-Thode Fouzia NERV Common Stock D 0
2015-04-16 2015-02-02 4/A Beer Marc D NERV Stock Option (right to buy) A - Award D 7 500 7 500
2015-04-16 2015-04-14 4 Ahlholm Frederick W NERV Stock Option (right to buy) A - Award D 5,19 57 524 57 524
2015-04-16 2015-04-14 4 Race Geoff NERV Stock Option (right to buy) A - Award D 5,19 213 133 213 133
2015-04-16 2015-04-14 4 Luthringer Remy NERV Stock Option (right to buy) A - Award D 5,19 399 623 399 623
2015-04-16 2015-04-14 4 Reilly Joseph H. NERV Stock Option (right to buy) A - Award D 5,19 57 524 57 524
2015-04-16 2015-04-14 4 Levine Mark S. NERV Stock Option (right to buy) A - Award D 5,19 57 524 57 524
2015-03-20 2015-03-18 4 De Rubertis Francesco See Footnotes NERV Warrant Shares P - Purchase I 5,77 0,1250 202 634 25 202 634
2015-03-20 2015-03-18 4 De Rubertis Francesco See Footnotes NERV Common Stock P - Purchase I 4,8100 202 634 975 5 488 272
2015-03-20 2015-03-18 4 Care Capital III LLC NERV Common Stock S - Sale I 6,2500 −6 700 −42 1 662 592
2015-03-20 2015-03-18 4 Care Capital III LLC NERV Common Stock S - Sale I 5,7500 −1 200 000 −6 900 1 669 292
2015-03-20 2015-03-18 4 Ollier Michele See Footnotes NERV Warrant Shares P - Purchase I 5,77 0,1250 202 634 25 202 634
2015-03-20 2015-03-18 4 Ollier Michele See Footnotes NERV Common Stock P - Purchase I 4,8100 202 634 975 5 488 272
2015-03-20 2015-03-18 4 Index Venture Associates III Ltd See Footnotes NERV Warrant Shares P - Purchase I 5,77 0,1250 202 634 25 202 634
2015-03-20 2015-03-18 4 Index Venture Associates III Ltd See Footnotes NERV Common Stock P - Purchase I 4,8100 202 634 975 5 488 272
2015-03-17 2015-03-13 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation- JJDC, Inc. NERV Warrants (right to buy) P - Purchase I 5,77 0,1250 607 903 76 607 903
2015-03-17 2015-03-13 4 JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. NERV Common Stock P - Purchase I 4,8100 607 903 2 924 4 500 159
2015-02-04 2015-02-02 4 VAN HEEK G JAN NERV Stock Option (right to buy) A - Award D 7 500 7 500
2015-02-04 2015-02-02 4 Beer Marc D NERV Stock Option (right to buy) A - Award D 7 500 7 500
2015-01-26 2015-01-26 4 Care Capital III LLC NERV Common Stock S - Sale I 5,0200 −23 111 −116 2 869 292
2015-01-26 2015-01-23 4 Care Capital III LLC NERV Common Stock S - Sale I 5,1400 −63 304 −325 2 892 403
2015-01-26 2015-01-22 4 Care Capital III LLC NERV Common Stock S - Sale I 5,1100 −395 697 −2 022 2 955 707
2015-01-08 2015-01-08 4 Care Capital III LLC NERV Common Stock S - Sale I 5,6600 −70 659 −400 3 351 404
2015-01-08 2015-01-07 4 Care Capital III LLC NERV Common Stock S - Sale I 5,8500 −64 278 −376 3 422 063
2015-01-08 2015-01-06 4 Care Capital III LLC NERV Common Stock S - Sale I 7,9400 −396 871 −3 151 3 486 341
2014-09-03 2014-09-02 4 Levine Mark S. NERV Employee Stock Option (Right to Buy) A - Award D 7,10 93 541 93 541
2014-09-03 3 Vandervelpen Nico NERV No securities are beneficially owned. D 0
2014-07-17 3 Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation NERV Common Stock I 6 568 706
2014-07-17 3 Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation NERV Common Stock I 6 568 706
2014-07-17 3 Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation NERV Common Stock I 6 568 706
2014-07-11 2014-06-30 4 Luthringer Remy NERV Employee Stock Option (Right to Buy) A - Award D 6,00 207 869 649 842
2014-07-11 2014-06-30 4 Luthringer Remy NERV Employee Stock Option (Right to Buy) A - Award D 6,00 441 973 441 973
2014-07-09 2014-06-30 4 Beer Marc D NERV Stock Option (Right to Buy) A - Award D 6,00 127 513 127 513
2014-07-09 2014-07-01 4 VAN HEEK G JAN NERV Common Stock P - Purchase D 6,0000 3 333 20 3 333
2014-07-09 2014-06-30 4 VAN HEEK G JAN NERV Stock Option (Right to Buy) A - Award D 6,00 51 967 51 967
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −61 922 −372 0
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −114 077 −684 0
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Common Stock P - Purchase I 6,0000 333 333 2 000 5 285 638
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Common Stock P - Purchase I 6,0000 1 287 500 7 725 4 952 305
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Common Stock C - Conversion I 6,0000 61 922 372 3 664 805
2014-07-09 2014-07-07 4 Ollier Michele See Footnotes NERV Common Stock C - Conversion I 6,0000 114 077 684 3 602 883
2014-07-09 2014-07-01 4 Ahlholm Frederick W NERV Common Stock P - Purchase D 6,0000 10 000 60 10 000
2014-07-09 2014-06-30 4 Ahlholm Frederick W NERV Employee Stock Option (Right to Buy) A - Award D 6,00 93 541 93 541
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −61 923 −372 0
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −114 078 −684 0
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Common Stock P - Purchase I 6,0000 737 500 4 425 3 883 212
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Common Stock C - Conversion I 6,0000 61 923 372 3 145 712
2014-07-09 2014-07-07 4 Care Capital III LLC See footnotes NERV Common Stock C - Conversion I 6,0000 114 078 684 3 083 789
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −61 922 −372 0
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −114 077 −684 0
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Common Stock P - Purchase I 6,0000 333 333 2 000 5 285 638
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Common Stock P - Purchase I 6,0000 1 287 500 7 725 4 952 305
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Common Stock C - Conversion I 6,0000 61 922 372 3 664 805
2014-07-09 2014-07-07 4 De Rubertis Francesco See footnotes NERV Common Stock C - Conversion I 6,0000 114 077 684 3 602 883
2014-07-09 2014-07-01 4 Vivaldi Coelho Rogerio NERV Common Stock P - Purchase D 6,0000 41 667 250 41 667
2014-07-09 2014-06-30 4 Vivaldi Coelho Rogerio NERV Employee Stock Option (right to buy) A - Award D 6,00 498 621 498 621
2014-07-09 2014-07-01 4 Race Geoff NERV Common Stock P - Purchase D 6,0000 33 333 200 206 648
2014-07-09 2014-06-30 4 Race Geoff NERV Employee Stock Option (Right to Buy) A - Award D 6,00 249 442 346 585
2014-07-09 2014-06-30 4 Race Geoff NERV Employee Stock Option (Right to Buy) A - Award D 6,00 97 143 97 143
2014-07-09 2014-07-01 4 Reilly Joseph H. NERV Common Stock P - Purchase D 6,0000 8 333 50 8 333
2014-07-09 2014-06-30 4 Reilly Joseph H. NERV Employee Stock Option (Right to Buy) A - Award D 6,00 93 541 93 541
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −61 923 −372 0
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −114 078 −684 0
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Common Stock P - Purchase I 6,0000 737 500 4 425 3 883 212
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Common Stock C - Conversion I 6,0000 61 923 372 3 145 712
2014-07-09 2014-07-07 4 Pellegrini Lorenzo See footnotes NERV Common Stock C - Conversion I 6,0000 114 078 684 3 083 789
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −61 922 −372 0
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Convertible Promissory Note C - Conversion I 6,00 6,0000 −114 077 −684 0
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Common Stock P - Purchase I 6,0000 333 333 2 000 5 285 638
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Common Stock P - Purchase I 6,0000 1 287 500 7 725 4 952 305
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Common Stock C - Conversion I 6,0000 61 922 372 3 664 805
2014-07-09 2014-07-07 4 Index Venture Associates III Ltd See footnotes NERV Common Stock C - Conversion I 6,0000 114 077 684 3 602 883
2014-06-30 3 Ollier Michele See Footnotes NERV Common Stock I 6 873 796
2014-06-30 3 Ollier Michele See Footnotes NERV Common Stock I 6 873 796
2014-06-30 3 Care Capital Offshore Investments III LP See Footnotes NERV Common Stock I 5 939 422
2014-06-30 3 Care Capital Offshore Investments III LP See Footnotes NERV Common Stock I 5 939 422
2014-06-30 3 Care Capital Offshore Investments III LP See Footnotes NERV Common Stock I 5 939 422
2014-06-30 3 Care Capital Offshore Investments III LP See Footnotes NERV Common Stock I 5 939 422
2014-06-30 3 De Rubertis Francesco See Footnotes NERV Common Stock I 6 873 796
2014-06-30 3 De Rubertis Francesco See Footnotes NERV Common Stock I 6 873 796
2014-06-30 3 Race Geoff NERV Common Stock D 346 630
2014-06-30 3 Race Geoff NERV Common Stock D 346 630
2014-06-30 3 Luthringer Remy By Wint2felden Holding SA NERV Common Stock I 1 853 208
2014-06-30 3 Luthringer Remy By Wint2felden Holding SA NERV Common Stock I 1 853 208
2014-06-30 3 Pellegrini Lorenzo See Footnotes NERV Common Stock I 5 939 422
2014-06-30 3 Pellegrini Lorenzo See Footnotes NERV Common Stock I 5 939 422
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6 873 796
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6 873 796
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6 873 796
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6 873 796
2014-06-30 3 Index Venture Associates V Ltd See Footnotes NERV Common Stock I 6 873 796
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Other Listings
DE:4MNA 1,65 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista